CSL logo — company profile

CSL

Founded 1916 Australia Melbourne, Australia 23077 employees Post Ipo Equity Total: $111.00M Biotechnology, Health Care

General Information

Company Name CSL
Founded Year 1916
Location Australia Melbourne, Australia +2
Founders / Decision Makers
Team member
Employees 23077
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when CSL moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CSL

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis, and nephrology. Since its start in 1916, the company has been driven by its promise to save lives using the latest technologies. Today, CSL, including its businesses, CSL Behring, CSL Seqirus, and CSL Vifor, provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Its unique combination of commercial strength, R&D focus, and operational excellence enables it to identify, develop, and deliver innovations so that patients can live life to the fullest.

See their community guidelines here: https://bit.ly/3Bs17Ra

Taxonomy: lifesaving medicines, haemophilia treatment, immune deficiencies treatment, vaccines, influenza prevention, iron deficiency therapies, dialysis treatments, nephrology treatments, global reach, commercial strength, R&D focus, operational excellence, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 06 Feb 2004

CSL Alternatives & Competitors

CSL vs

Innovative treatments for cancer: empowering patients with advanced research in cell therapies, anti...

Seed
Biotechnology, Health Care
CSL vs

Our mission is to utilize innovation and compassion to help our patients advance forward to a more f...

24 employees
Health Care, Health and Wellness
CSL vs
N'AGE
N'AGE Denmark

Nordic Beauty

146 employees
Health Care

FAQ About CSL

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr...
CSL was founded in 1916.
CSL is headquartered in Melbourne, Australia.
CSL operates in the following industries: Biotechnology, Health Care.
CSL has approximately 23077 employees.
CSL has completed 1 funding round, raising a total of $111.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to CSL include DAAN Biotherapeutics, Kadima Neuropsychiatry Institute, N'AGE, CSL Plasma, Jorja Healthcare Regenerative Treatments. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CSL and DAAN Biotherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CSL and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy